Balanced news tone
News Sentiment
BYSI sentiment intelligence
BeyondSpring Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
82/100 classification confidence.
directly relevant articles
high-authority source matches
-23.0% over one week, -8.3% over four weeks, trend inactive, and near fair-value range.
BeyondSpring (BYSI) Q1 2026 Earnings: EPS Loss of -$0.05 Amid No Revenue and Stock Decline - Guidance vs Actual
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 13 Jul 2026 12:30
- Source
- Market source
BeyondSpring (BYSI) Q1 2026 Earnings: EPS Loss of -$0.05 Amid No Revenue and Stock Decline - Guidance vs Actual
- Tone
- Negative 18/100
- Event
- Earnings
- Published
- 07 Jul 2026 23:44
- Source
- DonanımHaber
Form 4 BeyondSpring Inc For: 6 July By Investing.com
This article provides an announcement regarding a Form 4 filing for BeyondSpring Inc. on July 6. It briefly mentions the company's stock symbol BYSI and includes standard market data alongside the short notice. The core content is the notification of the regulatory filing, withou
- Tone
- Neutral 50/100
- Event
- Regulatory and legal
- Published
- 06 Jul 2026 18:16
- Source
- Investing.com Nigeria
BeyondSpring (BYSI) CEO Qiu Min reports direct holding of 2,498 Ordinary Shares
BeyondSpring Inc. CEO Qiu Min has reported a direct ownership of 2,498 Ordinary Shares in a recent Form 3 filing. This disclosure serves as an initial statement of beneficial ownership, establishing a baseline for the CEO's holdings rather than indicating a new buy or sell transa
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 Jul 2026 17:39
- Source
- Stock Titan
BeyondSpring (BYSI) director receives 100,000 stock options grant
BeyondSpring Inc. director Majeti Jiangwen was granted 100,000 stock options to purchase ordinary shares, with an exercise price of $1.75 per share and an expiration date of July 1, 2036. The options will vest in four equal 25% installments annually, contingent on Jiangwen's cont
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 Jul 2026 17:39
- Source
- Stock Titan
BeyondSpring (BYSI) CEO awarded 100,000 stock options at $1.75 strike price
BeyondSpring Inc. CEO Qiu Min has been granted 100,000 stock options with a strike price of $1.75 per share, expiring on July 1, 2036. These options, part of her compensation under the 2017 Omnibus Incentive Plan, will vest in four equal 25% installments annually, contingent on h
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 Jul 2026 17:39
- Source
- Stock Titan
BeyondSpring (BYSI) CFO Li Na submits initial Form 3 ownership filing
BeyondSpring Inc. (BYSI) CFO Li Na has filed her initial Form 3, which is a statement of beneficial ownership, with the SEC. This filing serves as the first formal record of her holdings in the company as an officer, but it reports no transactions, acquisitions, or derivative pos
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 06 Jul 2026 16:40
- Source
- Stock Titan
BeyondSpring (BYSI) finalizes CEO Min Qiu salary, bonus and option grant
BeyondSpring Inc. (BYSI) has finalized the employment terms for its new CEO, Min Qiu, as detailed in an amended 8-K filing. His compensation package includes an annual base salary of $100,000, eligibility for an annual bonus targeting 30% of his base salary, and options to purcha
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 Jun 2026 20:39
- Source
- Stock Titan
BeyondSpring (BYSI) Q1 2026 Earnings: Net Loss of -$0.05 Per Share as Clinical Programs Advance - Revenue Guidance Range
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 29 Jun 2026 07:00
- Source
- DonanımHaber
Price to sales forward of BeyondSpring, Inc. – NASDAQ:BYSI
This article mentions BeyondSpring, Inc. (NASDAQ: BYSI) and briefly touches upon its financial metric, "Price to sales forward." The content provided is minimal and appears to be an unpopulated or partial financial data page from TradingView, stating "No trades" and "Period Value
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 28 Jun 2026 11:40
- Source
- TradingView
Enterprise value to EBITDA forward of BeyondSpring, Inc. – NASDAQ:BYSI
This article provides a financial overview of BeyondSpring, Inc. (NASDAQ: BYSI) focusing on its enterprise value to EBITDA forward metric. The content indicates that the company's financial data is available through TradingView, which sources information from ICE Data Services an
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 27 Jun 2026 23:10
- Source
- TradingView
Enterprise value to revenue forward of BeyondSpring, Inc. – NASDAQ:BYSI
The article provides a financial metric, "Enterprise value to revenue forward," for BeyondSpring, Inc. (NASDAQ: BYSI). It is presented on TradingView's platform, indicating that the market for this stock is currently closed with no active trades. The information includes standard
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 27 Jun 2026 10:10
- Source
- TradingView
Price to book forward of BeyondSpring, Inc. – NASDAQ:BYSI
This article provides financial information for BeyondSpring, Inc. under its NASDAQ ticker BYSI, specifically focusing on its Price to Book Forward metric. It appears to be a stub or a data-focused page from TradingView, lacking detailed analysis but presenting the company's fina
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 27 Jun 2026 07:40
- Source
- TradingView
BeyondSpring Inc. Actuals & Estimates (NASDAQ:BYSI)
This article provides financial actuals and estimates for BeyondSpring Inc. (NASDAQ:BYSI), including its current stock price, historical performance, market capitalization, and upcoming earnings report date. It also addresses common questions about BYSI's stock, such as volatilit
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 25 Jun 2026 16:41
- Source
- TradingView
BeyondSpring Inc. (BYSI) Slips 2.48%: Stock Tests Key Support at $1.49 - Cumulative Volume
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 Jun 2026 07:00
- Source
- DonanımHaber
BeyondSpring Inc. (BYSI) Q1 2026 Earnings: Narrowing Losses Amid Strategic Clinical Progress - Analyst Drop Coverage
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 21 Jun 2026 07:00
- Source
- dars.gov.et
Beyondspring Inc (BYSI) Shareholder Structure: Major Shareholders & Institutional Holdings
This article details the shareholder structure of Beyondspring Inc (BYSI), listing major individual and institutional holders, as well as the proportion held by various shareholder types. It provides a historical overview of institutional shareholding from Q4 2023 to Q1 2026, sho
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Jun 2026 05:39
- Source
- TradingKey
Beyondspring Inc (BYSI) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution
This article from TradingKey focuses on Beyondspring Inc (BYSI) and attempts to provide a revenue breakdown by business segments and regions. However, it explicitly states that the relevant financial data has not been disclosed by the company yet, meaning no specific figures or i
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 18 Jun 2026 05:39
- Source
- TradingKey
Beyondspring Inc (BYSI) Institutional Confidence
Beyondspring Inc (BYSI) has an institutional shareholding score of 3.00, placing it 193rd out of 389 in the Biotechnology & Medical Research industry. The institutional shareholding proportion is 14.61%, which is a decrease of 9.34% quarter-over-quarter. James Simons is the large
- Tone
- Negative 40/100
- Event
- Market update
- Published
- 18 Jun 2026 04:46
- Source
- TradingKey
Beyondspring Inc (BYSI) Dividends & Stock Splits: Historical Payouts and Event Timeline
This article provides a historical overview of Beyondspring Inc (BYSI) regarding its dividends and stock splits. It explicitly states that the company has not distributed any dividends over the past five years and has no recorded stock split data. The page also includes current s
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Jun 2026 03:39
- Source
- TradingKey
Beyondspring Inc (BYSI) Earnings Forecast: Future EPS & Revenue Growth Estimates
This article provides an earnings forecast for Beyondspring Inc (BYSI), noting that no earnings forecast score is currently available for the company, contrasting with the Biotechnology & Medical Research industry's average score of 8.13. It also states that relevant financial fo
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 17 Jun 2026 09:10
- Source
- TradingKey
Beyondspring Inc (BYSI) Valuation: PE, PB & Fair Value Analysis
Beyondspring Inc (BYSI) currently holds a valuation score of 8.38, ranking 140th out of 388 in the Biotechnology & Medical Research industry. The company's P/E ratio is -8.49, which is significantly below its recent high but above its recent low. Key valuation metrics such as P/B
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jun 2026 09:10
- Source
- TradingKey
Beyondspring Inc (BYSI) Technical Analysis: Support, Resistance, Indicators & Moving Averages
This article provides a technical analysis of Beyondspring Inc (BYSI), detailing its price momentum score of 9.05 and positioning within the Biotechnology & Medical Research industry. It highlights the stock's trading range between resistance at $1.85 and support at $1.26, indica
- Tone
- Negative 39/100
- Event
- Market update
- Published
- 17 Jun 2026 09:10
- Source
- TradingKey
BeyondSpring (NASDAQ: BYSI) overhauls leadership to drive DUBLIN-4 lung cancer program
BeyondSpring Inc. (NASDAQ: BYSI) announced a major leadership transition aimed at advancing its DUBLIN-4 confirmatory Phase 3 trial for Plinabulin in non-small cell lung cancer. Founder and CEO Dr. Lan Huang will step down as CEO but remain Chair of the Board, focusing her operat
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 08 Jun 2026 15:10
- Source
- Stock Titan
BeyondSpring Announces Major Leadership Transition and New CEO
BeyondSpring (BYSI) has announced a significant leadership change, effective July 1, 2026. Founder Dr. Lan Huang will step down as CEO but remain as chair, focusing on SEED Therapeutics, while Min Qiu will take over as the new CEO. The company also appointed Dr. Jiangwen Majeti a
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Jun 2026 15:10
- Source
- The Globe and Mail
BYSI - BeyondSpring Inc Stock Price and Quote
This page provides a detailed financial overview and news updates for BeyondSpring Inc. (BYSI), a biotechnology company focused on immuno-oncology cancer therapies. It includes real-time stock quotes, key financial metrics, analyst ratings history, and a compilation of recent pre
- Tone
- Negative 39/100
- Event
- Analyst action
- Published
- 04 Jun 2026 23:40
- Source
- Finviz
BeyondSpring names new CEO, CFO as founder shifts to chairman role By Investing.com
BeyondSpring Inc. has announced a leadership transition effective July 1, 2026, with Min Qiu appointed as CEO and Na Li as CFO. Founder Dr. Lan Huang will move to a Chairman role, while Dr. Jiangwen Majeti becomes Vice Chairman. The company is advancing its Phase 3 trial for Plin
- Tone
- Positive 71/100
- Event
- Market update
- Published
- 04 Jun 2026 16:42
- Source
- Investing.com South Africa
BeyondSpring Elevates Min Qiu to CEO, Names Na Li CFO in Leadership Transition
BeyondSpring Inc. has announced a significant leadership transition, appointing Min Qiu as CEO and Na Li as CFO, effective July 1, 2026. Founder Dr. Lan Huang will remain Chairman while focusing on SEED Therapeutics. This restructuring aims to align management with the operationa
- Tone
- Positive 70/100
- Event
- Market update
- Published
- 04 Jun 2026 16:42
- Source
- citybiz
BeyondSpring Inc. Appoints Na Li as Chief Financial Officer, Effective July 1, 2026
BeyondSpring Inc. has appointed Ms. Na Li as its new Chief Financial Officer, effective July 1, 2026. Ms. Li brings over two decades of finance leadership experience from the pharmaceutical, biotechnology, and public-company sectors, including previous CFO roles. Her expertise in
- Tone
- Positive 70/100
- Event
- Market update
- Published
- 04 Jun 2026 13:42
- Source
- www.marketscreener.com
BeyondSpring Announces Leadership Transition to Deliver Focused Execution on Its Confirmatory DUBLIN-4 Program and Long-Term Value
BeyondSpring Inc. has announced a significant leadership transition effective July 1, 2026, aimed at focusing on the DUBLIN-4 Phase 3 program for Plinabulin. Dr. Lan Huang will remain Chairman of BeyondSpring while also leading SEED Therapeutics, and Min Qiu has been appointed CE
- Tone
- Positive 71/100
- Event
- Market update
- Published
- 04 Jun 2026 07:00
- Source
- GlobeNewswire